Mariner Wealth Advisors (NYC)’s AbbVie ABBV Stock Holding History

Mariner Wealth Advisors (NYC)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$232K	Buy	+3,968	New	+$240K	0.11%	50

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mariner Wealth Advisors (NYC)'s ABBV Position: Q1 2015 in Review

Mariner Wealth Advisors (NYC) opened a new position in AbbVie (ABBV) in Q1 2015: 3,968 shares worth $232K. The stake represents 0.11% of the portfolio and ranks #50 among its holdings.

1,601 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

Mariner Wealth Advisors (NYC) held 3,968 shares of AbbVie worth $232K as of Q1 2015.
AbbVie was a new Mariner Wealth Advisors (NYC) position in Q1 2015.
AbbVie made up 0.11% of Mariner Wealth Advisors (NYC)'s portfolio in Q1 2015, its #50 holding.
1,601 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Mariner Wealth Advisors (NYC)'s 13F filing for Q1 2015, filed 14 May 2015.